AlphaNavi Pharma
AlphaNavi Pharma is a biotech company in Suita, Japan, founded in 2019. It has 2 recorded funding rounds, most recently a Series B in March 2023.
AlphaNavi PharmaAlphaNavi Pharma株式会社
- Headquarters
- Suita, Osaka
- Founded
- 2019
- Business Model
- B2B
- Website
- alphanavi.com
- Last Round
- Series BMar 2023
- Rounds
- 2
Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.
About
AlphaNavi Pharma conducts research and development into new treatments for pain. Its development work addresses intractable pain and neuropathic pain, alongside other conditions for which existing therapies have not provided sufficient efficacy, focusing on patients whose pain remains inadequately treated.
Summary
Its most recent funding was a Series B round in Mar 2023. Investors include Kyoto University Innovation Capital, SMBC Venture Capital and Shinsei.
Tech & App Stack
Funding History
Mar 2023
Investors
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/alphanavi-pharma"><img src="https://indexed.vc/api/badge/company/alphanavi-pharma" alt="AlphaNavi Pharma on Indexed.vc" width="260" height="76" /></a>